Evidence map›Paper›PMID 27127179›Full record

ArticleOncotarget2016

Genetic association of deleted in colorectal carcinoma variants with breast cancer risk: A case-control study.

Xinghan Liu, Xijing Wang, Sidney W Fu, Meng Wang, Huafeng Kang, Haitao Guan, Shuqun Zhang, Xiaobin Ma, Shuai Lin, Kang Liu and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Cancer management and research · 2018
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Xinghan LiuDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Xijing WangDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Sidney W FuDivision of Genomic Medicine/Department of Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
Meng WangDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Huafeng KangDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Haitao GuanDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Shuqun ZhangDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Xiaobin MaDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Shuai LinDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Kang LiuDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Yanjing FengDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Cong DaiDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Zhijun DaiDepartment of Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Second Affiliated Hospital of Xi'an Jiaotong University · CNGeorge Washington University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deleted in colorectal carcinoma (DCC), a netrin-1 dependence receptor, is correlated with cell progression, migration, and adhesion. Evidence indicated that DCC was frequently down-regulated in many cancers. However, the association of DCC with breast cancer remains uncertain. We conducted a case-control study to investigate the impact of three DCC gene variants (rs2229080, rs7504990, and rs4078288) on breast cancer susceptibility in Chinese women. This study included 560 breast cancer patients and 583 age-matched healthy controls from Northwest China. The three gene variants were genotyped via Sequenom MassARRAY. Odds ratios (ORs) and 95% confidence intervals (CIs) were utilized to evaluate the associations. We found that individuals with the rs2229080 C/G, C/C, and C/G-CC genotypes had a higher breast cancer risk, and the minor allele C was associated with increased breast cancer risk in an allele model. We observed a significantly decreased breast cancer risk with the rs7504990 C/T, T/T, and C/T-T/T genotypes, and the minor allele T was protective against breast cancer in an allele model. In addition, rs2229080 was associated with the axillary lymph node (LN) metastasis status. An age-stratified analysis revealed an association between rs2229080 and reduced breast cancer risk among older patients (≥ 49 years). Furthermore, the haplotype analysis showed that the Crs2229080Crs7504990Ars4078288 haplotype was associated with a decreased breast cancer risk. However, the results indicated a lack of association between rs4078288 and breast cancer risk. These findings affirmed that rs2229080 and rs7504990 polymorphisms in DCC might be related with breast cancer susceptibility in Chinese women.

Indexed as

Polymorphism, Single NucleotideAdultAge FactorsAsian PeopleBiomarkers, TumorBreast NeoplasmsCase-Control StudiesChinaDCC ReceptorFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHaplotypesHeterozygoteHomozygoteBiomarkers, TumorDCC protein, humanDCC Receptorbreast cancercase-controlDCCgene variantsusceptibility

Identifiers

PMID27127179
PMCPMC5078049
OpenAlexW2344268151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.